abstract |
The present invention relates to the field of oncolytic viruses, in particular to recombinant rhabdoviruses encoding the CCL21 protein in its genome, eg bullous stomatitis virus. The present invention further relates to the use of recombinant viruses in the treatment of cancer, and also to methods for producing such viruses. |